Even still, the pharma deals announced out of the event brought a clear message for the biotech industry. Technology ...

Biotech investors are reeling after the sudden departure of Dr. Peter Marks, a pivotal figure in the U.S. Food and Drug ...

(Reuters) -Shares of U.S. biotech companies fell as much as 10% premarket on Monday following reports that a top vaccine ...

Pattie Hunt Sinacole shares advice on next steps The post Rescinded biotech offer, now what? appeared first on Boston.com.

Biotech stocks plunge after Dr. Peter Marks resigns from FDA, citing disputes with RFK Jr. over vaccines and drug approvals.

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

Recursion Pharmaceuticals uses artificial intelligence (AI) in its proprietary operating system to match new compounds against a vast library of human genes in order to come up with new therapies.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Trinity Biotech (NASDAQ:TRIB – Get Free Report) will likely be announcing its earnings results before the market opens on ...

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...

Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ...

Analysts expect Evaxion Biotech to report an earnings per share (EPS) of $-0.15. Evaxion Biotech bulls will hope to hear the ...